Satellos Bioscience Inc.

TSX:MSCL Stock Report

Market Cap: CA$85.2m

Satellos Bioscience Future Growth

Future criteria checks 0/6

Satellos Bioscience's earnings are forecast to decline at 15.1% per annum. EPS is expected to grow by 0.6% per annum.

Key information

-15.1%

Earnings growth rate

0.6%

EPS growth rate

Biotechs earnings growth32.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated18 Nov 2024

Recent future growth updates

No updates

Recent updates

Is Satellos Bioscience (TSE:MSCL) In A Good Position To Deliver On Growth Plans?

Oct 07
Is Satellos Bioscience (TSE:MSCL) In A Good Position To Deliver On Growth Plans?

We're Hopeful That Satellos Bioscience (TSE:MSCL) Will Use Its Cash Wisely

Apr 11
We're Hopeful That Satellos Bioscience (TSE:MSCL) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Satellos Bioscience's (CVE:MSCL) Cash Burn Situation

Dec 22
Here's Why We're Not Too Worried About Satellos Bioscience's (CVE:MSCL) Cash Burn Situation

Will Satellos Bioscience (CVE:MSCL) Spend Its Cash Wisely?

Apr 08
Will Satellos Bioscience (CVE:MSCL) Spend Its Cash Wisely?

Earnings and Revenue Growth Forecasts

TSX:MSCL - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-32N/A-272
12/31/2025N/A-27-21-222
12/31/2024N/A-27-22-222
9/30/2024N/A-29-23-23N/A
6/30/2024N/A-23-22-22N/A
3/31/2024N/A-21-20-20N/A
12/31/2023N/A-16-15-15N/A
9/30/2023N/A-14-10-10N/A
6/30/2023N/A-13-8-8N/A
3/31/2023N/A-11-5-5N/A
12/31/2022N/A-11-6-6N/A
9/30/2022N/A-9-6-6N/A
6/30/2022N/A-18-7-7N/A
3/31/2022N/A-17-7-7N/A
12/31/2021N/A-16-5-5N/A
9/30/2021N/A-13-5-5N/A
6/30/20210-2-2-2N/A
3/31/2021N/A-2-1-1N/A
12/31/2020N/A-2-2-2N/A
12/31/20190-2-2-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MSCL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MSCL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MSCL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if MSCL's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: MSCL is forecast to have no revenue next year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MSCL's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y